{"id":59191,"date":"2024-03-13T11:56:51","date_gmt":"2024-03-13T14:56:51","guid":{"rendered":"https:\/\/med.estrategia.com\/portal\/?p=59191"},"modified":"2024-04-26T10:32:23","modified_gmt":"2024-04-26T13:32:23","slug":"gabarito-recursos-revalida-inep-2024-1","status":"publish","type":"post","link":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/","title":{"rendered":"Revalida INEP 2024.1: confira o gabarito definitivo da prova objetiva"},"content":{"rendered":"<p>No <strong>domingo, 17 de mar&ccedil;o<\/strong>, mais de 10 mil candidatos participaram da <strong>primeira etapa do Revalida INEP 2024.1 <\/strong>&mdash; primeira edi&ccedil;&atilde;o do processo de revalida&ccedil;&atilde;o de diplomas de medicina do Instituto Nacional de Estudos e Pesquisas Educacionais An&iacute;sio Teixeira no ano.<br><br>Com a <strong><a href=\"https:\/\/med.estrategia.com\/portal\/noticias\/divulgada-a-nota-de-corte-da-1a-etapa-do-revalida-2024-1\/\" target=\"_blank\">nota de corte estabelecida em 91,96&nbsp;pontos<\/a><\/strong> para garantir a classifica&ccedil;&atilde;o para a segunda etapa do processo<strong>, os participantes foram avaliados por meio de duas provas te&oacute;ricas: prova objetiva (P1)<\/strong>, composta por 100 quest&otilde;es de m&uacute;ltipla escolha e, <strong>prova discursiva (P2)<\/strong>, com 5 quest&otilde;es discursivas. <br><br>Se voc&ecirc; prestou a primeira etapa do Revalida INEP 2024.1, ou est&aacute; se preparando para a pr&oacute;xima edi&ccedil;&atilde;o, <strong>n&atilde;o deixe de conferir a corre&ccedil;&atilde;o dos professores especialistas do Estrat&eacute;gia MED <\/strong>e divulga&ccedil;&atilde;o do gabarito! Confira detalhes abaixo.<p>\n\n\n<div id=\"new-form\">\n\t<form id=\"forms_layout\">\n\t<input type=\"hidden\" id=\"chave_de\" name=\"chave_de\" value=\"01_EMED_LEADS_TOTAIS\" \/>\n\t\t<input type=\"hidden\" id=\"mid\" name=\"mid\" value=\"515009018\" \/>\n\t\t<input type=\"hidden\" id=\"Objetivo\" name=\"Objetivo\" value=\"Medicina\" \/>\n\t\t<input type=\"hidden\" id=\"Estado_de_Origem_do_IP\" name=\"Estado_de_Origem_do_IP\"  value=\"\" \/>\n\t\t<input type=\"hidden\" id=\"Cidade_de_Origem_do_IP\" name=\"Cidade_de_Origem_do_IP\" value=\"\" \/>\n\t\t<input type=\"hidden\" id=\"Modo_de_entrada\" name=\"Modo_de_entrada\" value=\"Portal\" \/>\n\t\t<input type=\"hidden\" id=\"Pagina_Origem\" name=\"Pagina_Origem\" value=\"\" \/>\n\n\t\t<div class=\"texto\">\n\t\t\t<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_79_2 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\">Navegue pelo conte\u00fado<\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Inscreva-se-em-nossa-newsletter\" >Inscreva-se em nossa newsletter!<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Gabarito-e-Recursos-Revalida-INEP-20241\" >Gabarito e Recursos Revalida INEP 2024.1<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Gabarito-Revalida-INEP-20241-do-Estrategia-MED\" >Gabarito Revalida INEP 2024.1 do Estrat&eacute;gia MED<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Prova-Objetiva-Revalida-INEP-20241\" >Prova Objetiva Revalida INEP 2024.1<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Prova-Discursiva-Revalida-INEP-20241\" >Prova Discursiva Revalida INEP 2024.1<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#Cronograma-1a-Etapa-%E2%80%93-Revalida-INEP-20241\" >Cronograma 1&ordf; Etapa &ndash; Revalida INEP 2024.1<\/a><\/li><\/ul><\/nav><\/div>\n<h3 class=\"news\"><span class=\"ez-toc-section\" id=\"Inscreva-se-em-nossa-newsletter\"><\/span>Inscreva-se em nossa newsletter!<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\t\t\t<p>Receba not\u00edcias sobre resid\u00eancia m\u00e9dica, revalida\u00e7\u00e3o de diplomas e concursos m\u00e9dicos, al\u00e9m de materiais de estudo gratuitos e informa\u00e7\u00f5es relevantes do mundo da Medicina.<\/p>\n\t\t<\/div>\n\t\t<div class=\"campos\">\n\t\t\t<div class=\"first_name labels\">\n\t\t\t\t<input type=\"text\" class=\"input_labels\" id=\"first_name\" name=\"Nome_Completo\" placeholder=\"Nome\" required \/>\n\t\t\t<\/div>\n\t\t\t<div class=\"email labels\">\n\t\t\t\t<input type=\"email\" class=\"input_labels\" id=\"email\" name=\"Email\" placeholder=\"E-mail\" required \/>\n\t\t\t<\/div>\n\t\t\t<button type=\"submit\" class=\"button_layout\">\n\t\t\t\t<div id=\"lblBotao\">Inscreva-se<\/div>\n\t\t\t\t<span id=\"divSpiner\" class=\"loader\" role=\"status\" style=\"display: none;\"><\/span>\t\n\t\t\t<\/button>\n\t\t<\/div><!-- \/campos -->\n\t\t\n\t\t<label class=\"container_checkbox\">Voc\u00ea concorda com a nossa\n\t\t\t<a class=\"politics_privacy_ahref\" target=\"_blank\" href=\"https:\/\/gratis.estrategiaconcursos.com.br\/politica-de-privacidade\/\">Pol\u00edtica de Privacidade<\/a> e aceita receber informa\u00e7\u00f5es adicionais do Estrat\u00e9gia Educacional.\n\t\t\t<input id=\"checkbox_layout\" type=\"checkbox\" checked=\"checked\" required \/>\n\t\t\t<span class=\"checkbox\"><\/span>\n\t\t<\/label>\n\t\t<div id=\"msg\"><\/div>\n\t\t<div id=\"error\" class=\"error\">\n\t\t<\/div>\n\t<\/form>\n<\/div><!-- \/new-form -->\n\n\n\n<\/p><h2 class=\"wp-block-heading\" id=\"h-gabarito-e-recursos-revalida-inep-2024-1\"><span class=\"ez-toc-section\" id=\"Gabarito-e-Recursos-Revalida-INEP-20241\"><\/span>Gabarito e Recursos Revalida INEP 2024.1<span class=\"ez-toc-section-end\"><\/span><\/h2><p>Com <strong>o gabarito e do padr&atilde;o esperado de respostas preliminares<\/strong> divulgados no <strong>dia 20 <\/strong>deste m&ecirc;s, os candidatos tiveram at&eacute; o dia 26 de mar&ccedil;o para interpor recursos contra as quest&otilde;es e gabarito. Em seguida, o gabarito definitivo da prova objetiva foi divulgado junto ao resultado definitivo da P1 e preliminar da P2. Confira:<\/p><div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/GABARITO_PRELIMINAR.pdf\" target=\"_blank\">GABARITO PRELIMINAR<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/PADRAO_RESPOSTA_PRELIMINAR.pdf\" target=\"_blank\">PADR&Atilde;O ESPERADO DE RESPOSTAS PRELIMINAR<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/04\/GABARITO_DEFINITIVO_revalida.pdf\" target=\"_blank\">gabarito definitivo &ndash; prova objetiva<\/a><\/div>\n<\/div><p>E para ajudar os candidatos a elaborarem os recursos, os professores especialistas do Estrat&eacute;gia MED prepararam&nbsp;<strong>modelos, com a argumenta&ccedil;&atilde;o e refer&ecirc;ncia bibliogr&aacute;fica&nbsp;<\/strong>de cada quest&atilde;o pass&iacute;vel de questionamento da prova. Acompanhe as atualiza&ccedil;&otilde;es abaixo:<\/p><div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-2 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-DISCURSIVA_Q01.pdf\" target=\"_blank\">DISCURSIVA &ndash; QUEST&Atilde;O 01, ITEM B<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/Recurso-Revalida-INEP-questao-5-item-E.pdf\" target=\"_blank\">discursiva &ndash; quest&atilde;o 5, item e<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q28.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 28<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q43.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 43<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q46.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 46<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q50.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 50<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q57.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 57<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/Recurso-Revalida-2024-questao-68.pdf\" target=\"_blank\">objetiva &ndash; quest&atilde;o 68<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/REVALIDA_2024_1-OBJETIVA_Q85.pdf\" target=\"_blank\">OBJETIVA &ndash; QUEST&Atilde;O 85<\/a><\/div>\n<\/div><p>Caso necess&aacute;rio,&nbsp;<strong>o recurso precisa ser apresentado de maneira adequada e com uma estrutura correta<\/strong>&nbsp;e, como o Estrat&eacute;gia MED est&aacute;&nbsp;<a href=\"https:\/\/med.estrategia.com\/portal\/?s=revalida\" target=\"_blank\">presente em todas as etapas do Revalida<\/a>, preparamos tamb&eacute;m um guia para te auxiliar neste momento. O<strong>&nbsp;&ldquo;Guia Revalida: como elaborar um recurso irrecus&aacute;vel?&rdquo;<\/strong>&nbsp;&eacute;&nbsp;<em>gratuito e j&aacute; est&aacute; dispon&iacute;vel<\/em>&nbsp;clicando na imagem abaixo:<\/p><figure class=\"wp-block-image size-large is-resized\"><a href=\"https:\/\/gratis.estrategiaconcursos.com.br\/emed-revalida-como-elaborar-um-recurso-irrecusavel-2024\/\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/infraweb-landing-pages-prod.s3.amazonaws.com\/medicina\/ebook-revalida\/image\/banner.image\" alt=\"\" style=\"width:680px;height:auto\"><\/a><\/figure><h2 class=\"wp-block-heading\" id=\"h-gabarito-revalida-inep-2024-1-do-estrategia-med\"><span class=\"ez-toc-section\" id=\"Gabarito-Revalida-INEP-20241-do-Estrategia-MED\"><\/span>Gabarito Revalida INEP 2024.1 do Estrat&eacute;gia MED<span class=\"ez-toc-section-end\"><\/span><\/h2><p>Os<strong>&nbsp;professores especialistas do Estrat&eacute;gia MED<\/strong>&nbsp;estiveram&nbsp;<strong>ao vivo&nbsp;<\/strong>em&nbsp;<a href=\"https:\/\/www.youtube.com\/c\/Estrat%C3%A9giaMED\" target=\"_blank\">nosso canal do YouTube<\/a>&nbsp;comandando a&nbsp;<strong>corre&ccedil;&atilde;o de todas as 100 quest&otilde;es objetivas aplicadas, bem como as 5 quest&otilde;es discursivas,<\/strong> sanando d&uacute;vidas e sinalizando poss&iacute;veis detalhes que possam ser pass&iacute;veis de recursos contra quest&otilde;es ou gabarito preliminar, se necess&aacute;rio.<\/p><p>A transmiss&atilde;o da corre&ccedil;&atilde;o aconteceu no<strong>&nbsp;dia 17 de mar&ccedil;o<\/strong> e voc&ecirc; pode conferir neste mesmo texto:<\/p><h3 class=\"wp-block-heading\" id=\"h-prova-objetiva-revalida-inep-2024-1\"><span class=\"ez-toc-section\" id=\"Prova-Objetiva-Revalida-INEP-20241\"><\/span>Prova Objetiva Revalida INEP 2024.1<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>1 &ndash; <\/strong>A<\/td><td><strong>21 &ndash; <\/strong>B<\/td><td><strong>41 &ndash; <\/strong>D<\/td><td><strong>61 &ndash; <\/strong>D<\/td><td><strong>81 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>2 &ndash; <\/strong>A<\/td><td><strong>22 &ndash; <\/strong>D<\/td><td><strong>42 &ndash; <\/strong>A<\/td><td><strong>62<\/strong> &ndash; C<\/td><td><strong>82 &ndash; <\/strong>B<\/td><\/tr><tr><td><strong>3 &ndash; <\/strong>C<\/td><td><strong>23 &ndash; <\/strong>A<\/td><td><strong>43<\/strong> &ndash; *<\/td><td><strong>63 &ndash; <\/strong>B<\/td><td><strong>83 &ndash; <\/strong>D<\/td><\/tr><tr><td><strong>4 &ndash; <\/strong>D<\/td><td><strong>24 &ndash; <\/strong>B<\/td><td><strong>44 &ndash; <\/strong>B<\/td><td><strong>64 &ndash; <\/strong>D<\/td><td><strong>84 &ndash; <\/strong>A<\/td><\/tr><tr><td><strong>5 &ndash; <\/strong>A*<\/td><td><strong>25 &ndash; <\/strong>C<\/td><td><strong>45 &ndash; <\/strong>D*<\/td><td><strong>65 &ndash; <\/strong>A<\/td><td><strong>85 &ndash; <\/strong>D<\/td><\/tr><tr><td><strong>6 &ndash; <\/strong>D<\/td><td><strong>26 &ndash; <\/strong>D<\/td><td><strong>46 &ndash; <\/strong>A<\/td><td><strong>66 &ndash; <\/strong>A<\/td><td><strong>86 &ndash; <\/strong>B<\/td><\/tr><tr><td><strong>7 &ndash; <\/strong>D<\/td><td><strong>27 &ndash; <\/strong>A*<\/td><td><strong>47 &ndash; <\/strong>D<\/td><td><strong>67 &ndash; <\/strong>C<\/td><td><strong>87 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>8 &ndash; <\/strong>C<\/td><td><strong>28 &ndash; <\/strong>B<\/td><td><strong>48 &ndash; <\/strong>D<\/td><td><strong>68 &ndash; <\/strong>A<\/td><td><strong>88 &ndash; <\/strong>B<\/td><\/tr><tr><td><strong>9 &ndash; <\/strong>B<\/td><td><strong>29 &ndash; <\/strong>C<\/td><td><strong>49 &ndash; <\/strong>C<\/td><td><strong>69<\/strong> &ndash; C<\/td><td><strong>89 &ndash; <\/strong>B<\/td><\/tr><tr><td><strong>10 &ndash; <\/strong>D<\/td><td><strong>30 &ndash; <\/strong>B<\/td><td><strong>50<\/strong> &ndash; *<\/td><td><strong>70 &ndash; <\/strong>D<\/td><td><strong>90 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>11 &ndash; <\/strong>D<\/td><td><strong>31 &ndash; <\/strong>C<\/td><td><strong>51 &ndash; <\/strong>A<\/td><td><strong>71 &ndash; <\/strong>C<\/td><td><strong>91 &ndash; <\/strong>A<\/td><\/tr><tr><td><strong>12 &ndash; <\/strong>A<\/td><td><strong>32<\/strong> &ndash; D<\/td><td><strong>52 &ndash; <\/strong>B<\/td><td><strong>72 &ndash; <\/strong>A<\/td><td><strong>92 &ndash; <\/strong>D<\/td><\/tr><tr><td><strong>13 &ndash; <\/strong>C<\/td><td><strong>33 &ndash; <\/strong>B<\/td><td><strong>53 &ndash; <\/strong>B<\/td><td><strong>73 &ndash; <\/strong>A<\/td><td><strong>93 &ndash; <\/strong>A<\/td><\/tr><tr><td><strong>14 &ndash; <\/strong>D<\/td><td><strong>34 &ndash; <\/strong>C<\/td><td><strong>54 &ndash; <\/strong>B<\/td><td><strong>74 &ndash; <\/strong>B<\/td><td><strong>94 &ndash; <\/strong>D<\/td><\/tr><tr><td><strong>15 &ndash; <\/strong>C<\/td><td><strong>35 &ndash; <\/strong>B<\/td><td><strong>55 &ndash; <\/strong>A<\/td><td><strong>75 &ndash; <\/strong>B<\/td><td><strong>95 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>16 &ndash; <\/strong>A<\/td><td><strong>36 &ndash; <\/strong>D<\/td><td><strong>56 &ndash; <\/strong>C<\/td><td><strong>76 &ndash; <\/strong>C<\/td><td><strong>96 &ndash; <\/strong>A<\/td><\/tr><tr><td><strong>17 &ndash; <\/strong>D<\/td><td><strong>37 &ndash; <\/strong>C<\/td><td><strong>57 &ndash; <\/strong>A\/B*<\/td><td><strong>77 &ndash; <\/strong>B<\/td><td><strong>97 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>18 &ndash; <\/strong>D<\/td><td><strong>38 &ndash; <\/strong>B<\/td><td><strong>58 &ndash; <\/strong>C*<\/td><td><strong>78 &ndash; <\/strong>D<\/td><td><strong>98 &ndash; <\/strong>B<\/td><\/tr><tr><td><strong>19 &ndash; <\/strong>D<\/td><td><strong>39 &ndash; <\/strong>A<\/td><td><strong>59 &ndash; <\/strong>D<\/td><td><strong>79 &ndash; <\/strong>B<\/td><td><strong>99 &ndash; <\/strong>C<\/td><\/tr><tr><td><strong>20 &ndash; <\/strong>D<\/td><td><strong>40 &ndash; <\/strong>A<\/td><td><strong>60 &ndash; <\/strong>A<\/td><td><strong>80 &ndash; <\/strong>B<\/td><td><strong>100 &ndash; <\/strong>A<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Quest&otilde;es com alternativas destacadas com * s&atilde;o pass&iacute;veis de recursos, de acordo com os professores do Estrat&eacute;gia MED<\/figcaption><\/figure><h3 class=\"wp-block-heading\" id=\"h-prova-discursiva-revalida-inep-2024-1\"><span class=\"ez-toc-section\" id=\"Prova-Discursiva-Revalida-INEP-20241\"><\/span>Prova Discursiva Revalida INEP 2024.1<span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-table\"><table><tbody><tr><td><strong>1. a)<\/strong> Doen&ccedil;a de Alzheimer.<br>(valor: 3,0 pontos)<\/td><\/tr><tr><td><strong>b)<\/strong> Hipertens&atilde;o Arterial Sist&ecirc;mica.<br>*Ressalva de que Diabetes Melittus tamb&eacute;m est&aacute; correto, dependendo do gabarito.<br>(valor: 2,0 pontos)<\/td><\/tr><tr><td><strong>c)<\/strong> Hipotiroidismo, Neurossifilis e defici&ecirc;ncia de vitamina B12.<br>*Ressalva de que Hidrocefalia de press&atilde;o normal, dem&ecirc;ncia vascular, dem&ecirc;ncia por corp&uacute;sculos de Lewy e dem&ecirc;ncia fronto-temporal tamb&eacute;m deveriam ser aceitos, dependendo do gabarito.<br>(valor: 3,0 pontos)<\/td><\/tr><tr><td><strong>d)<\/strong> Rivastigmina, Donepezila, Galantamina ou Memantina.<br>(valor: 2,0 pontos)<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table><tbody><tr><td><strong>2. a)<\/strong> Paralisia de corda vocal (ou Les&atilde;o do nervo laringeo recorrente.<br>(valor: 3,0 pontos)<\/td><\/tr><tr><td><strong>b)<\/strong> Hipocalcemia, manobras de Trousseau e de Chvostek.<br>(valor: 3,0 pontos)<\/td><\/tr><tr><td><strong>c)<\/strong> Hipotireoidismo prim&aacute;rio e levotiroxina. Hipoparatireoidismo prim&aacute;rio e hipocalcemia sintom&aacute;tico, gluconato de c&aacute;lcio (tratamento imediato), com posterior tratamento cr&ocirc;nico do hipoparatireoidismo cr&ocirc;nico com carbonato de c&aacute;lcio e calcitriol.<br>(valor: 4,0 pontos)<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table><tbody><tr><td><strong>3. a)<\/strong> Crise grave. Hipoxemia, uso de musculatura acess&oacute;ria (tiragem intercostal e de f&uacute;rcula), taquicardia e taquipneia.<br>(valor: 3,0 pontos)<\/td><\/tr><tr><td><strong>b)<\/strong> &#9679; Monitoriza&ccedil;&atilde;o;<br>&#9679; Oximetria de pulso;<br>&#9679; Avalia&ccedil;&atilde;o da press&atilde;o arterial;<br>&#9679; Interna&ccedil;&atilde;o;<br>&#9679;Oferta de oxig&ecirc;nio;<br>&#9679; Sulfato de magn&eacute;sio (50 mg\/kg e deve ser infundida em 30 minutos);<br>&#9679; Manter SABA e corticoterapia.<br>(valor: 3,5 pontos)<\/td><\/tr><tr><td><strong>c)<\/strong> &#9679; Infec&ccedil;&otilde;es respirat&oacute;rias (v&iacute;rus, bact&eacute;rias);<br>&#9679; Exposi&ccedil;&atilde;o a al&eacute;rgenos (inalante, alimentar e ocupacional);<br>&#9679; Irritantes respirat&oacute;rios inalados (fuma&ccedil;a de tabaco e ar frio e seco);<br>&#9679; Temperatura e clima;<br>&#9679; Atividade f&iacute;sica;<br>&#9679; Flutua&ccedil;&otilde;es hormonais;<br>&#9679; Medicamentos, principalmente os betabloqueadores, AAS (&aacute;cido acetilsalic&iacute;lico).<br>&#9679; Fatores emocionais (ansiedade, estresse, etc).<br>(valor: 3,5 pontos)<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table><tbody><tr><td><strong>4. a)<\/strong> N&atilde;o. <br>Fase ativa: a partir dos 5 cm de dilata&ccedil;&atilde;o com contra&ccedil;&otilde;es fortes e regulares. <br>(valor: 4,0 pontos)<\/td><\/tr><tr><td><strong>b)<\/strong> N&atilde;o.<br>A interna&ccedil;&atilde;o deve ocorrer na fase ativa do trabalho de parto, a gestante est&aacute; na fase latente.<br>(valor: 2,5 pontos)<\/td><\/tr><tr><td><strong>c)<\/strong> &#9679; Educa&ccedil;&atilde;o Perinatal;<br>&#9679; T&eacute;cnicas de respira&ccedil;&atilde;o, relaxamento, hipnose;<br>&#9679; Apoio cont&iacute;nuo durante o parto;<br>&#9679; Movimenta&ccedil;&atilde;o e mudan&ccedil;a de posi&ccedil;&atilde;o;<br>&#9679; Bola de parto;<br>&#9679; Hidroterapia;<br>&#9679; Massagem;<br>&#9679; Acupuntura, acupress&atilde;o, TENS;<br>&#9679; Musicoterapia e aromaterapia.<br>(valor: 1,5 ponto)<\/td><\/tr><tr><td><strong>d)<\/strong> Perda de l&iacute;quido, parada da movimenta&ccedil;&atilde;o fetal, sangramento vaginal, piora das contra&ccedil;&otilde;es.<br>(valor: 2,0 pontos)<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table><tbody><tr><td><strong>5. a)<\/strong> Manchas vermelhas em membros superiores, t&oacute;rax e membros inferiores; Artralgia.<br>(valor: 2,0 pontos)<\/td><\/tr><tr><td><strong>b)<\/strong> Febre Chikungunya.<br>(valor: 1,0 ponto)<\/td><\/tr><tr><td><strong>c)<\/strong> Dengue e leptospirose.<br>(valor: 1,0 ponto)<\/td><\/tr><tr><td><strong>d)<\/strong> 1) RT-PCR para chikungunya em amostra de sangue;<br>2) Analgesia;<br>3) Hidrata&ccedil;&atilde;o oral;<br>4) Notifica&ccedil;&atilde;o compuls&oacute;ria;<br>5) Orientar retorno no caso de persist&ecirc;ncia da febre por mais de 5 dias ou no aparecimento de sinais de gravidade.<br>(valor: 5,0 pontos)<\/td><\/tr><tr><td><strong>e)<\/strong> O novo Guia de Vigil&acirc;ncia em Sa&uacute;de traz uma s&eacute;rie de a&ccedil;&otilde;es que podem ser realizadas para as arboviroses brasileiras cl&aacute;ssicas (dengue, zika e chikungunya). Provavelmente o gabarito vir&aacute; considerando essas a&ccedil;&otilde;es, onde o candidato precisa escolher apenas duas:<br><br>1 &ndash; Construir, manter, alimentar e retroalimentar sistemas de informa&ccedil;&otilde;es de dengue, chikungunya e Zika, visando ao acompanhamento dessas arboviroses e &agrave; constru&ccedil;&atilde;o de indicadores epidemiol&oacute;gicos para orientar a&ccedil;&otilde;es, avaliar efetividade dos programas de preven&ccedil;&atilde;o e controle, assim como apoiar estudos e pesquisas voltadas ao aprimoramento da vigil&acirc;ncia e do controle.<br>2 &ndash; Monitorar a ocorr&ecirc;ncia de casos graves de dengue, chikungunya e Zika, assim como as manifesta&ccedil;&otilde;es at&iacute;picas de chikungunya e a cronicidade da doen&ccedil;a, a ocorr&ecirc;ncia de Zika em gestantes e os casos de manifesta&ccedil;&otilde;es neurol&oacute;gicas, possivelmente, relacionados &agrave; infec&ccedil;&atilde;o pr&eacute;via por esses arbov&iacute;rus.<br>3 &ndash; Contribuir para a redu&ccedil;&atilde;o da magnitude de ocorr&ecirc;ncia de dengue, chikungunya e Zika, por meio da identifica&ccedil;&atilde;o oportuna de &aacute;reas com maior n&uacute;mero de casos, visando orientar a&ccedil;&otilde;es integradas de preven&ccedil;&atilde;o, controle e organiza&ccedil;&atilde;o da assist&ecirc;ncia.<br>4 &ndash; Investigar oportunamente os &oacute;bitos suspeitos ou confirmados de dengue, chikungunya e Zika, mediante identifica&ccedil;&atilde;o de seus poss&iacute;veis determinantes e defini&ccedil;&atilde;o de estrat&eacute;gias para aprimoramento do manejo adequado e oportuno aos casos, evitando a ocorr&ecirc;ncia de novos &oacute;bitos.<br>5 &ndash; Fornecer indicadores epidemiol&oacute;gicos e entomol&oacute;gicos que apoiem o desenvolvimento das a&ccedil;&otilde;es de controle dessas arboviroses, bem como, monitorar a situa&ccedil;&atilde;o em sa&uacute;de e da gest&atilde;o no territ&oacute;rio. <br>6 &ndash; Realizar monitoramento para detec&ccedil;&atilde;o oportuna da circula&ccedil;&atilde;o viral de dengue, chikungunya e Zika, incluindo alerta para poss&iacute;veis mudan&ccedil;as no padr&atilde;o de circula&ccedil;&atilde;o desses arbov&iacute;rus. <br>7 &ndash; Considere tamb&eacute;m a&ccedil;&otilde;es de controle qu&iacute;mico e biol&oacute;gico do vetor mais prevalente (Aedes aegypti), busca ativa de casos pelos agentes comunit&aacute;rios e orienta&ccedil;&atilde;o da popula&ccedil;&atilde;o quanto &agrave; elimina&ccedil;&atilde;o de&nbsp;focos&nbsp;caseiros.<br>(valor: 1,0 ponto)<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"cs-embed cs-embed-responsive\"><iframe title=\"Gabarito Revalida INEP 2024.1 | Corre&ccedil;&atilde;o de Prova ao Vivo\" width=\"1200\" height=\"675\" src=\"https:\/\/www.youtube.com\/embed\/kcEYFWLcBTM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure><h2 class=\"wp-block-heading\" id=\"h-cronograma-1&ordf;-etapa-revalida-inep-2024-1\"><span class=\"ez-toc-section\" id=\"Cronograma-1a-Etapa-%E2%80%93-Revalida-INEP-20241\"><\/span>Cronograma 1&ordf; Etapa &ndash; Revalida INEP 2024.1<span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\">\n<li><strong>Inscri&ccedil;&otilde;es:&nbsp;<\/strong>29\/01 a 02\/02\/2024;<\/li>\n\n\n\n<li><strong>Envio do Diploma:<\/strong>&nbsp;29\/01 a 02\/02\/2024;<\/li>\n\n\n\n<li><strong>Solicita&ccedil;&atilde;o de atendimento especializado:<\/strong>&nbsp;29\/01 a 02\/02\/2024;<\/li>\n\n\n\n<li><strong>Pagamento da taxa de inscri&ccedil;&atilde;o:&nbsp;<\/strong>29\/01 a 07\/02\/2024;<\/li>\n\n\n\n<li><strong>Resultado da An&aacute;lise do Diploma:<\/strong>&nbsp;07\/02\/2024;<\/li>\n\n\n\n<li><strong>Recurso contra resultado da An&aacute;lise:<\/strong>&nbsp;07 a 16\/02\/2024;<\/li>\n\n\n\n<li><strong>Resultado do Recurso:<\/strong>&nbsp;23\/02\/2024;<\/li>\n\n\n\n<li><strong>Divulga&ccedil;&atilde;o da nota de corte da 1&ordf; Etapa:<\/strong>&nbsp;22\/02\/2024;<\/li>\n\n\n\n<li><strong>Divulga&ccedil;&atilde;o do cart&atilde;o de confirma&ccedil;&atilde;o de inscri&ccedil;&atilde;o:<\/strong>&nbsp;04\/03\/2024;<\/li>\n\n\n\n<li><strong>Aplica&ccedil;&atilde;o:<\/strong>&nbsp;17\/03\/2024;<\/li>\n\n\n\n<li><strong>Gabarito preliminar da prova objetiva objetiva (P1) e do padr&atilde;o de resposta da prova escrita discursiva (P2):<\/strong>&nbsp;20\/03\/2024;<\/li>\n\n\n\n<li><strong>Recurso ao gabarito preliminar:<\/strong>&nbsp;20 a 26\/03\/2024;<\/li>\n\n\n\n<li><strong>Resultados do recurso e gabarito definitivo:<\/strong>&nbsp;26\/04\/2024;<\/li>\n\n\n\n<li><strong>Resultado Definitivo Prova Objetiva (P1):<\/strong>&nbsp;26\/04\/2024;<\/li>\n\n\n\n<li><strong>Resultado preliminar Prova Escrita Discursiva (P2):<\/strong>&nbsp;26\/04\/2024;&nbsp;&nbsp;<\/li>\n\n\n\n<li><strong>Recurso contra Resultado preliminar (P2):<\/strong>&nbsp;26\/04 a 02\/05\/2024; e<\/li>\n\n\n\n<li><strong>Divulga&ccedil;&atilde;o dos resultados finais da 1&ordf; Etapa:<\/strong>&nbsp;23\/05\/2024.<\/li>\n<\/ul><p>\n\n\n\n\n\n\n<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores especialistas do Estrat\u00e9gia MED\n","protected":false},"author":39,"featured_media":59847,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wl_entities_gutenberg":"","footnotes":""},"categories":[300],"tags":[],"wl_entity_type":[199],"class_list":{"0":"post-59191","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-noticias","8":"wl_entity_type-article"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Gabarito Revalida 2024.1 do Estrat\u00e9gia MED<\/title>\n<meta name=\"description\" content=\"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revalida INEP 2024.1: confira o gabarito definitivo da prova objetiva\" \/>\n<meta property=\"og:description\" content=\"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Estrat\u00e9gia MED\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/estrategiamed1\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-13T14:56:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-26T13:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana Carolina Damasceno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:site\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Carolina Damasceno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/\",\"name\":\"Gabarito Revalida 2024.1 do Estrat\u00e9gia MED\",\"isPartOf\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg\",\"datePublished\":\"2024-03-13T14:56:51+00:00\",\"dateModified\":\"2024-04-26T13:32:23+00:00\",\"author\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c\"},\"description\":\"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.\",\"breadcrumb\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Estrat\u00e9gia MED\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/med.estrategia.com\/portal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/med.estrategia.com\/portal\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Revalida INEP 2024.1: confira o gabarito definitivo da prova objetiva\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\",\"url\":\"https:\/\/med.estrategia.com\/portal\/\",\"name\":\"Estrat\u00e9gia MED\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c\",\"name\":\"Ana Carolina Damasceno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2021\/09\/WhatsApp-Image-2023-08-18-at-16.46.43-150x150.jpeg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2021\/09\/WhatsApp-Image-2023-08-18-at-16.46.43-150x150.jpeg\",\"caption\":\"Ana Carolina Damasceno\"},\"description\":\"Coordenadora de Jornalismo EMED. Comunicadora por natureza e forma\u00e7\u00e3o, que ama e perde a no\u00e7\u00e3o do tempo com m\u00fasica e s\u00e9rie.\",\"url\":\"https:\/\/med.estrategia.com\/portal\/author\/ana-carolina-damasceno\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gabarito Revalida 2024.1 do Estrat\u00e9gia MED","description":"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/","og_locale":"pt_BR","og_type":"article","og_title":"Revalida INEP 2024.1: confira o gabarito definitivo da prova objetiva","og_description":"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.","og_url":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/","og_site_name":"Estrat\u00e9gia MED","article_publisher":"https:\/\/www.facebook.com\/estrategiamed1","article_published_time":"2024-03-13T14:56:51+00:00","article_modified_time":"2024-04-26T13:32:23+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg","type":"image\/jpeg"}],"author":"Ana Carolina Damasceno","twitter_card":"summary_large_image","twitter_creator":"@estrategiamed_","twitter_site":"@estrategiamed_","twitter_misc":{"Escrito por":"Ana Carolina Damasceno","Est. tempo de leitura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/","url":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/","name":"Gabarito Revalida 2024.1 do Estrat\u00e9gia MED","isPartOf":{"@id":"https:\/\/med.estrategia.com\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage"},"image":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage"},"thumbnailUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg","datePublished":"2024-03-13T14:56:51+00:00","dateModified":"2024-04-26T13:32:23+00:00","author":{"@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c"},"description":"Confira a corre\u00e7\u00e3o da primeira etapa do Revalida INEP 2024.1 comandada pelo time de professores do Estrat\u00e9gia MED e atualiza\u00e7\u00f5es do processo.","breadcrumb":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#primaryimage","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2024\/03\/revalida-inep-2024.1.jpg","width":1280,"height":720,"caption":"Estrat\u00e9gia MED"},{"@type":"BreadcrumbList","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/gabarito-recursos-revalida-inep-2024-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.estrategia.com\/portal\/"},{"@type":"ListItem","position":2,"name":"Not\u00edcias","item":"https:\/\/med.estrategia.com\/portal\/noticias\/"},{"@type":"ListItem","position":3,"name":"Revalida INEP 2024.1: confira o gabarito definitivo da prova objetiva"}]},{"@type":"WebSite","@id":"https:\/\/med.estrategia.com\/portal\/#website","url":"https:\/\/med.estrategia.com\/portal\/","name":"Estrat\u00e9gia MED","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c","name":"Ana Carolina Damasceno","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2021\/09\/WhatsApp-Image-2023-08-18-at-16.46.43-150x150.jpeg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2021\/09\/WhatsApp-Image-2023-08-18-at-16.46.43-150x150.jpeg","caption":"Ana Carolina Damasceno"},"description":"Coordenadora de Jornalismo EMED. Comunicadora por natureza e forma\u00e7\u00e3o, que ama e perde a no\u00e7\u00e3o do tempo com m\u00fasica e s\u00e9rie.","url":"https:\/\/med.estrategia.com\/portal\/author\/ana-carolina-damasceno\/"}]}},"_wl_alt_label":[],"wl:entity_url":"\/post\/gabarito-recursos-revalida-inep-2024-1","_links":{"self":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/59191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/comments?post=59191"}],"version-history":[{"count":35,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/59191\/revisions"}],"predecessor-version":[{"id":68336,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/59191\/revisions\/68336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media\/59847"}],"wp:attachment":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media?parent=59191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/categories?post=59191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/tags?post=59191"},{"taxonomy":"wl_entity_type","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/wl_entity_type?post=59191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}